FRANKLIN, Tenn.--(BUSINESS WIRE)--May 11, 2015--
Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ:
ACHC) today announced the completion of an underwritten public offering
of 5,175,000 shares of Acadia’s common stock. Included in the shares are
675,000 shares sold by Acadia pursuant to the underwriters’ exercise in
full of their option to purchase additional shares of common stock.
The shares of common stock were sold at a public offering price of
$66.50 per share, for net proceeds to Acadia of approximately $331.1
million, after underwriting discounts and commissions and estimated
offering expenses. Acadia intends to use the proceeds from the offering
to repay outstanding indebtedness on the revolving line of credit under
its existing amended and restated senior credit agreement, to fund its
acquisition activity and for general corporate purposes.
BofA Merrill Lynch, Jefferies and UBS Investment Bank acted as joint
book-running managers for the offering, and Citigroup, Raymond James,
RBC Capital Markets, Avondale Partners, Baird and Craig-Hallum Capital
Group acted as co-managers. The shares of common stock were offered
pursuant to the Company’s shelf registration statement on file with the
Securities and Exchange Commission. The offering was made solely by
means of a prospectus supplement and accompanying prospectus, copies of
which may be obtained by contacting: (i) BofA Merrill Lynch, 222
Broadway, New York, New York 10038, Attn: Prospectus Department or by
e-mail at dg.prospectus_requests@baml.com;
(ii) Jefferies, Attention: Equity Syndicate Prospectus Department, 520
Madison Avenue, 2nd Floor, New York, NY 10022, by telephone at
(877) 547-6340 or by e-mail at prospectus_department@jefferies.com;
or (iii) UBS Investment Bank, Attention: Prospectus Department, 1285
Avenue of the Americas, New York, NY 10019, or by telephone at
(888) 827-7275.
This press release does not constitute an offer to sell or a
solicitation of an offer to buy these securities in any jurisdiction in
which such offer, solicitation or sale is unlawful.
Forward-Looking Statements
This news release contains forward-looking statements. Generally words
such as “may,” “will,” “should,” “could,” “anticipate,” “expect,”
“intend,” “estimate,” “plan,” “continue,” and “believe” or the negative
of or other variation on these and other similar expressions identify
forward-looking statements. These forward-looking statements are made
only as of the date of this news release. The Company does not undertake
to update or revise the forward-looking statements, whether as a result
of new information, future events or otherwise. Forward-looking
statements are based on current expectations and involve risks and
uncertainties.
About Acadia
Acadia is a provider of inpatient behavioral healthcare services. Acadia
operates a network of 208 behavioral healthcare facilities with
approximately 8,600 beds in 37 states, the United Kingdom and Puerto
Rico. Acadia provides psychiatric and chemical dependency services to
its patients in a variety of settings, including inpatient psychiatric
hospitals, residential treatment centers, outpatient clinics and
therapeutic school-based programs.
Source: Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc.
Brent Turner, 615-861-6000
President